Part one of our debrief following the Ignite Melbourne event held at MCRI in Melbourne earlier in the year. Learn who eas there and what was discussed.

What we learned at this year’s HealthXL Global Gathering. At this year’s gathering, two key themes dominated the discussions of the day:Clinical Trial Optimization: What are the barriers and opportunities? How do we sequence evidence generation within the field of digital therapeutics?

An analysis of the consumer diagnostic space, looking at the top funded companies, partnerships, notable activity etc, using the data from our HealthXL platform. We explore the biggest companies that are selling diagnostic kits direct to consumer.

In this weeks blog, we are doing a roundup of some notable investments that have occurred so far in 2019, assessing the types of companies that are catching the interest of investors, and exploring if these correlate to our previous predictions or if there are any new trends to add to your radar.

We recently released our Q1 report on Virtual Health Assistants (VHAs). As part of the report, we carried out a survey on consumers and clinicians. In this weeks blog, we examine the results of our survey to gain an insight into consumer and clinician awareness, adoption, and trust in VHAs.

In this weeks blog, we take a look at how the unprecedented public interest in the Theranos case has impacted the digital health space, sparking questions around digital health valuations, due diligence, and clinical evidence.

In this weeks blog, we explore why the ‘gold standard’ RCT in its current form is not necessarily the perfect fit for evaluating digital health solutions, and what some appropriate alternatives may be.

We’ve put together a list of 8 digital health trends to keep on your radar in 2019 based on everything we’ve read and heard from our members, advisors, friends at start-ups, and investors, coupled with data from the HealthXL platform to bring you a perfect mix of subjective and objective data.

In this week’s blog, we look at how digital health can play a role in clinical trials - from patient recruitment, to helping patients control their own trial experience, to collecting more regular and more accurate data from the trials.

Adequate payment for a digital health solution is essential to becoming successful and driving mainstream adoption. In this week's blog, we investigate which solutions are actually generating revenue, why and what business models have worked.

While technology is already transforming transportation and infrastructure systems in cities around the world, people are now recognising its potential to also tackle the health and environmental challenges associated with city living.

There has been much hype around healthcare consumerism lately, with direct-to-consumer digital health and wellness apps coming into the market at unprecedented rates - But can we really trust patients to filter through this noise and find true value?